Open Surgical Revascularization
Treatment for Vascular intestinal disorders
Effectiveness
90%
Safety Score
40%
Clinical Trials
1
Participants
8K
Comparative Safety Scale(Higher is safer)
Cyanide☠️
Meth💀
Cigarettes🚬
Chemo☢️
Alcohol🍺
Morphine💊
Antibiotics💉
Tylenol💊
Exercise🏃
Water💧
40
DangerousModerateSafe
Treatment Details
Time to Effect
Immediate
Treatment Duration
Single procedure, long-term monitoring
Evidence Quality
MODERATEConfidence Score
85%confidence in effectiveness data
Health Economics
Annual Cost of Care
Drug Cost:$100
Monitoring:$800
Side Effect Mgmt:$1,000
Total Annual:$1,900
Cost-Effectiveness Analysis
Cost-Effectiveness Rating
MODERATEICER
$95,000/QALY
QALYs Gained
2.2
Outcome-Based Costs
Cost per Responder
$2,111
Cost per Remission
$2,235
Comparison vs Endovascular Revascularization
Cost Difference
+$15,000/year
More expensive
QALY Difference
+0.10 QALYs
Better outcomes
Dominance
No dominance
Open Surgical Revascularization Outcomes
for Vascular intestinal disorders
Efficacy Outcomes
Overall Effectiveness
+90%
Response Rate
+90%
Remission Rate
+85%
Common Side Effects
Surgical site infection
+10%
Bleeding
+7%
Myocardial infarction
+5%
Stroke
+2%
Renal failure
+3%
WARNING: LIMITED TRIALS AVAILABLE
You can search for trials, but you probably can't join any because the 1% Treaty hasn't passed yet. Most trials are severely limited by lack of funding and bureaucratic barriers. Help change this!
Active Clinical Trials
No active trials currently recruiting for this treatment
No active trials found in ClinicalTrials.gov
Completed Clinical Trials
1 completed trial for Open Surgical Revascularization in Vascular intestinal disorders
Comparison of Outcomes of Patients With Stage IV Chronic Limb-threatening Ischemia and Colorectal Cancer
NCT05116696COMPLETED
836 participants
OBSERVATIONAL
Belgrade, Serbia
Started: Mar 1, 2021